Earnings quality
Compare earnings and operating cash flow for earnings quality.
Texas Instruments Incorporated
Ticker TXN · 🇺🇸 United States · Consolidated US GAAP · amounts in dollars
Filed 2026-02-06 · Period end 2025-12-31
Takeaway
Worth trackingSales and operating profit both moved in a healthier direction.
operating margin is 34.1%; equity ratio is 47.1%.
Sales and operating profit moved together — keep watching margins and whether the trend persists next period.
ActionWorth tracking
OP margin34.1%
Equity ratio47.1%
Last price—
Trailing P/E—
Look at next
- Compare operating cash flow to reported profit across the last two years.
- Open English IR for management commentary on outlook and capital allocation.
- Overlay peers on Compare before judging relative momentum.
About the company
TEXAS INSTRUMENTS INCORPORATED is a US-listed company with consolidated financial statements filed on SEC EDGAR.
Compare trends
Tel 9729953773 · As of filing date 2026-02-06
Financial statements
Income statement
| Account | FY2024 (ended Dec 31, 2024) | FY2025 (ended Dec 31, 2025) |
|---|---|---|
| Revenue | $15.6B | $17.7B |
| Cost of sales* | $6.5B | $7.6B |
| Gross profit | $9.1B | $10.1B |
| Operating profit | $5.5B | $6.0B |
| Income tax | $654.0M | $709.0M |
| Net income | $4.8B | $5.0B |
| Basic EPS | 5.24 | 5.47 |
Balance sheet
| Account | FY2024 (ended Dec 31, 2024) | FY2025 (ended Dec 31, 2025) |
|---|---|---|
| Cash & equivalents | $3.2B | $3.2B |
| Current assets | $15.0B | $13.8B |
| Non-current assets* | $20.5B | $20.8B |
| Total assets | $35.5B | $34.6B |
| Current liabilities | $3.6B | $3.2B |
| Non-current liabilities* | $15.0B | $15.2B |
| Total liabilities | $18.6B | $18.3B |
| Stockholders’ equity | $16.9B | $16.3B |
Cash flow statement
| Account | FY2024 (ended Dec 31, 2024) | FY2025 (ended Dec 31, 2025) |
|---|---|---|
| Operating cash flow | $6.3B | $7.2B |
| Investing cash flow | -$3.2B | -$1.4B |
| Financing cash flow | -$2.9B | -$5.7B |
| Cash at end of period | $3.2B | $3.2B |
Five-year trends
Key metrics
| Metric | Trend | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $18.3B | $20.0B | $17.5B | $15.6B | $17.7B | |
| Operating profit | $9.0B | $10.1B | $7.3B | $5.5B | $6.0B | |
| Net income | $7.8B | $8.7B | $6.5B | $4.8B | $5.0B | |
| Total assets | $24.7B | $27.2B | $32.3B | $35.5B | $34.6B | |
| Cash & equivalents | $4.6B | $3.0B | $3.0B | $3.2B | $3.2B | |
| Stockholders’ equity | $13.3B | $14.6B | $16.9B | $16.9B | $16.3B |
How we read these numbers
From the notes
No material one-offs extracted from this filing.
Constructive
Sales and operating profit both moved in a healthier direction.
On the income statement, revenue moved from $15.6B to $17.7B (▲ +13.0%). Operating profit went from $5.5B to $6.0B (▲ +10.2%).
Operating cash flow was $7.2B (prior $6.3B), with cash on the balance sheet at $3.2B versus $3.2B.
Liquidity & leverage
Cash moved from $3.2B to $3.2B; current liabilities $3.2B.
Capital buffer
Stockholders’ equity moved from $16.9B to $16.3B.
Was this page helpful?
Source: SEC EDGAR 0000097476-26-000059
(TEXAS INSTRUMENTS INCORPORATED), period end 2025-12-31.